Form 4: Cardinal Health Director Granted 1,067 RSUs

Cardinal Health director Sudhakar Ramakrishna was granted 1,067 restricted share units, vesting in November 2026.

Summary

• Sudhakar Ramakrishna, a Director of Cardinal Health Inc. (CAH), acquired 1,067 common shares in the form of restricted share units (RSUs) on November 5, 2025.
• The RSUs were granted at a price of $0, indicating they are part of compensation rather than a purchase.
• Following this transaction, Mr. Ramakrishna directly beneficially owns a total of 2,116 common shares.
• These restricted share units are scheduled to vest on November 5, 2026, or earlier if the 2026 Annual Meeting of Shareholders occurs before that date.

Sentiment

Score: 7

Explanation: The filing reports a routine equity grant to a director, which is a positive for aligning interests but not a significant market-moving event. The Power of Attorney is a standard administrative document.

Positives

• The grant of restricted share units aligns the director's long-term financial interests with those of Cardinal Health shareholders, incentivizing sustained company performance.
• This equity award represents a standard form of non-cash compensation for directors, reflecting continued engagement and commitment to the company.

Negatives

• No direct negatives are apparent from this routine compensation grant.

Risks

• The Limited Power of Attorney explicitly states that neither Cardinal Health nor any attorney-in-fact assumes liability for the undersigned's responsibility to comply with the requirements of the Exchange Act or the Securities Act, including reporting obligations under Section 16. The ultimate responsibility for compliance remains with Sudhakar Ramakrishna.

Future Outlook

The restricted share units granted are scheduled to vest on November 5, 2026, or earlier if the 2026 Annual Meeting of Shareholders precedes that date, representing a future equity event for the director.

Industry Context

The grant of restricted share units to a director is a standard practice in corporate governance across various industries, including healthcare distribution, to align executive and director incentives with long-term shareholder value creation.

Comparison to Industry Standards

• The grant of restricted stock units (RSUs) as part of director compensation is a common practice among publicly traded companies, including peers in the healthcare distribution sector such as McKesson Corporation (MCK) and AmerisourceBergen Corporation (ABC).
• The vesting schedule, tied to a future date or the annual shareholder meeting, is typical for such equity awards, aiming to retain directors and align their interests with long-term company performance.
• The specific number of units (1,067) would need to be evaluated against Cardinal Health's overall compensation philosophy and peer group benchmarks to determine if it falls within standard ranges for a director of this tenure and responsibility.

Corporate Governance

Related Party Transactions

• The RSU grant is a form of compensation from Cardinal Health to a director, which is a standard, disclosed related party transaction.

Stakeholder Impact

• Shareholders: The grant of RSUs aligns the director's long-term interests with shareholder value creation.
• Management: The Power of Attorney streamlines administrative tasks for SEC reporting related to the director's transactions.

Next Steps

• The restricted share units will vest on November 5, 2026, or the date of the 2026 Annual Meeting of Shareholders, whichever is earlier.

Key Dates

Recommendation

This Form 4 filing reports a routine equity grant to a director as part of their compensation, which is a standard corporate governance practice. It does not contain any information that would fundamentally alter the investment thesis for Cardinal Health Inc. The Power of Attorney is an administrative document. Therefore, a 'hold' recommendation is appropriate as this filing provides no new material information to warrant a change in investment stance.

Keywords

Cardinal Health, CAH, Sudhakar Ramakrishna, Restricted Share Units, RSU, Insider Transaction, Form 4, Director Compensation, Equity Grant